Kromek Group plc – LSE:KMK.L
Kromek Group stock price today
Kromek Group stock price monthly change
Kromek Group stock price quarterly change
Kromek Group stock price yearly change
Kromek Group key metrics
Market Cap | 32.14M |
Enterprise value | 1.55B |
P/E | -2.8 |
EV/Sales | 118.41 |
EV/EBITDA | -107.78 |
Price/Sales | 1.17 |
Price/Book | 0.34 |
PEG ratio | -0.34 |
EPS | -0.02 |
Revenue | 30.18M |
EBITDA | -2.92M |
Income | -11.50M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -126.07% |
Oper. margin | -36.12% |
Gross margin | 47.32% |
EBIT margin | -36.12% |
EBITDA margin | -9.7% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeKromek Group stock price history
Kromek Group stock forecast
Kromek Group financial statements
| Apr 2021 | 5.77M | -2.33M | -40.5% |
|---|---|---|---|
| Oct 2022 | 6.78M | -5.07M | -74.72% |
| Apr 2023 | 10.52M | -1.03M | -9.79% |
| Oct 2023 | 7.09M | -3.06M | -43.23% |
| 2023-07-24 | -0.004 | -0.00238 |
|---|---|---|
| 2024-01-30 | -0.00607 | -0.00607 |
| Oct 2020 | 60058000 | 18.51M | 30.84% |
|---|---|---|---|
| Apr 2021 | 70158000 | 20.10M | 28.65% |
| Oct 2022 | 67450000 | 18.47M | 27.38% |
| Oct 2023 | 68745000 | 21.43M | 31.18% |
| Oct 2021 | -2.36M | -3.48M | -466K |
|---|---|---|---|
| Oct 2022 | -4.35M | -2.84M | 2.44M |
| Apr 2023 | 3.84M | -2.42M | -456K |
| Oct 2023 | -2.39M | -2.80M | 7.72M |
Kromek Group alternative data
| Aug 2023 | 168 |
|---|---|
| Sep 2023 | 173 |
| Oct 2023 | 166 |
| Nov 2023 | 166 |
| Dec 2023 | 166 |
| Jan 2024 | 166 |
| Feb 2024 | 166 |
| Mar 2024 | 166 |
| Apr 2024 | 166 |
| May 2024 | 166 |
| Jun 2024 | 166 |
| Jul 2024 | 166 |
Kromek Group other data
| Patent |
|---|
Application Filling date: 7 May 2020 Issue date: 11 Nov 2021 |
Application Filling date: 31 Jul 2020 Issue date: 12 Nov 2020 |
Grant Filling date: 30 Jan 2019 Issue date: 19 May 2020 |
Grant Utility: Molecular breast imaging method Filling date: 9 Jul 2018 Issue date: 28 Apr 2020 |
Grant Utility: Molecular breast imaging system Filling date: 11 Apr 2016 Issue date: 14 Apr 2020 |
Grant Utility: Modular gamma imaging device Filling date: 19 Oct 2017 Issue date: 24 Mar 2020 |
Grant Utility: Photon scatter imaging Filling date: 22 Jun 2018 Issue date: 14 Jan 2020 |
Application Filling date: 22 Jun 2018 Issue date: 26 Dec 2019 |
Grant Utility: Sparse acquisition gamma cameras Filling date: 29 Mar 2017 Issue date: 10 Dec 2019 |
Grant Utility: Modular gamma imaging device Filling date: 13 Jun 2018 Issue date: 19 Nov 2019 |
| Insider | Compensation |
|---|---|
Dr. Arnab Basu MBE (1973) Chief Executive Officer & Executive Director | $231,000 |
Mr. Paul N. Farquhar (1962) Chief Financial Officer, Company Sec. & Director | $179,000 |
-
What's the price of Kromek Group stock today?
One share of Kromek Group stock can currently be purchased for approximately $16.38.
-
When is Kromek Group's next earnings date?
Unfortunately, Kromek Group's (KMK.L) next earnings date is currently unknown.
-
Does Kromek Group pay dividends?
No, Kromek Group does not pay dividends.
-
How much money does Kromek Group make?
Kromek Group has a market capitalization of 32.14M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 60.95% to 19.4M US dollars. Kromek Group made a loss 3.29M US dollars in net income (profit) last year or -$0.01 on an earnings per share basis.
-
What is Kromek Group's stock symbol?
Kromek Group plc is traded on the LSE under the ticker symbol "KMK.L".
-
What is Kromek Group's primary industry?
Company operates in the Technology sector and Hardware, Equipment & Parts industry.
-
How do i buy shares of Kromek Group?
Shares of Kromek Group can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Kromek Group's key executives?
Kromek Group's management team includes the following people:
- Dr. Arnab Basu MBE Chief Executive Officer & Executive Director(age: 52, pay: $231,000)
- Mr. Paul N. Farquhar Chief Financial Officer, Company Sec. & Director(age: 63, pay: $179,000)
-
How many employees does Kromek Group have?
As Jul 2024, Kromek Group employs 166 workers.
-
When Kromek Group went public?
Kromek Group plc is publicly traded company for more then 11 years since IPO on 16 Oct 2013.
-
What is Kromek Group's official website?
The official website for Kromek Group is kromek.com.
-
How can i contact Kromek Group?
Kromek Group can be reached via phone at +44 1740 626060.
Kromek Group company profile:
Kromek Group plc
kromek.comLSE
165
Hardware, Equipment & Parts
Technology
Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and devices for the medical imaging, civil nuclear industry, CBRNe security, and safety screening markets in the United Kingdom, North America, Asia, Europe, Australasia, and Africa. The company's products provide high-resolution information on material composition and structure that are used in various applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, as well as the analysis of radioactive materials. It also offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray, x-ray, and neutron detection. In addition, the company provides medical imaging products, including CZT gamma detectors for SPECT imaging, CZT bone mineral densitometry detectors, and photon-counting spectral CT systems. Further, it offers CBRNE homeland security products and solutions for government, border control, airport and seaports, HazMat teams, ambulance crews, police, and armed forces, as well as a range of gamma spectroscopy software that enables specialized gamma-ray spectroscopy for the analysis of samples. Additionally, the company provides CZT imaging development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array for laboratory and research imaging; and engages in the scientific research and development activities. It sells its products through distributors, OEMs, and direct sales. The company was incorporated in 2013 and is headquartered in Sedgefield, the United Kingdom.
Sedgefield, TS21 3FD
:
ISIN: GB00BD7V5D43
CUSIP: G5317Z102
